title: Extracellular matrix formation enhances the ability of Streptococcus pneumoniae to cause invasive disease.
abstract: During infection, pneumococci exist mainly in sessile biofilms rather than in planktonic form, except during sepsis. However, relatively little is known about how biofilms contribute to pneumococcal pathogenesis. Here, we carried out a biofilm assay on opaque and transparent variants of a clinical serotype 19F strain WCH159. After 4 days incubation, scanning electron microscopy revealed that opaque biofilm bacteria produced an extracellular matrix, whereas the transparent variant did not. The opaque biofilm-derived bacteria translocated from the nasopharynx to the lungs and brain of mice, and showed 100-fold greater in vitro adherence to A549 cells than transparent bacteria. Microarray analysis of planktonic and sessile bacteria from transparent and opaque variants showed differential gene expression in two operons: the lic operon, which is involved in choline uptake, and in the two-component system, ciaRH. Mutants of these genes did not form an extracellular matrix, could not translocate from the nasopharynx to the lungs or the brain, and adhered poorly to A549 cells. We conclude that only the opaque phenotype is able to form extracellular matrix, and that the lic operon and ciaRH contribute to this process. We propose that during infection, extracellular matrix formation enhances the ability of pneumococci to cause invasive disease.
authors: Research Centre for Infectious Diseases, School of Molecular and Biomedical Science, The University of Adelaide, Adelaide, South Australia, Australia.
authors: Claudia
authors: C
authors: Trappetti
authors: Abiodun D
authors: AD
authors: Ogunniyi
authors: Marco R
authors: MR
authors: Oggioni
authors: James C
authors: JC
authors: Paton
references: Prog Brain Res. 1993;98:197-200
references: 8248509
references: Mol Microbiol. 1994 May;12(3):505-15
references: 8065267
references: Infect Immun. 1995 Mar;63(3):757-61
references: 7868244
references: Mol Microbiol. 2009 Oct;74(2):395-408
references: 19737355
references: Vaccine. 2009 May 26;27(25-26):3245-50
references: 19200820
references: J Bacteriol. 2006 Nov;188(22):7785-95
references: 16936041
references: J Infect Dis. 2009 May 15;199(10):1497-505
references: 19392624
references: Methods. 2003 Dec;31(4):265-73
references: 14597310
references: Microbiology (Reading). 2006 Feb;152(Pt 2):305-311
references: 16436418
references: J Neurochem. 1978 Feb;30(2):299-308
references: 624938
references: J Infect Dis. 1998 Feb;177(2):368-77
references: 9466523
references: Infect Immun. 2001 Jan;69(1):602-6
references: 11119562
references: Infect Immun. 1996 Sep;64(9):3772-7
references: 8751928
references: J Infect Chemother. 2009 Jun;15(3):125-42
references: 19554398
references: Infect Immun. 2008 Nov;76(11):5049-61
references: 18794289
references: Gene Ther. 1997 Apr;4(4):375-7
references: 9176525
references: Infect Immun. 2009 Sep;77(9):3722-30
references: 19564377
references: Cell. 2000 Sep 15;102(6):827-37
references: 11030626
references: Cell Microbiol. 2009 Jul;11(7):1034-43
references: 19374653
references: J Bacteriol. 2007 May;189(10):3868-75
references: 17322318
references: JAMA. 2006 Jul 12;296(2):202-11
references: 16835426
references: Infect Immun. 2005 Aug;73(8):4653-67
references: 16040978
references: Microb Pathog. 2010 Mar-Apr;48(3-4):124-30
references: 20096771
references: DNA Res. 2009 Jun;16(3):177-86
references: 19429668
references: Science. 2001 Jul 20;293(5529):498-506
references: 11463916
references: Mol Microbiol. 2004 Mar;51(6):1661-75
references: 15009893
references: Nat Rev Microbiol. 2008 Apr;6(4):288-301
references: 18340341
references: Infect Immun. 1997 Mar;65(3):943-50
references: 9038301
references: Infect Immun. 2005 Jun;73(6):3210-8
references: 15908345
references: Am J Respir Crit Care Med. 2006 Jul 15;174(2):213-20
references: 16675778
references: Infection. 2009 Oct;37(5):450-4
references: 19280117
references: Proc Natl Acad Sci U S A. 2006 May 30;103(22):8505-10
references: 16707578
references: Infect Immun. 2008 Feb;76(2):646-57
references: 18039836
references: BMC Microbiol. 2008 Oct 08;8:173
references: 18842140
references: J Exp Med. 1998 Feb 16;187(4):631-40
references: 9463413
references: Microsc Res Tech. 2007 Sep;70(9):816-22
references: 17557287
references: J Bacteriol. 2009 Apr;191(8):2512-20
references: 19218382
references: J Bacteriol. 2010 Sep;192(17):4489-97
references: 20601473
references: Mol Microbiol. 1999 Mar;31(5):1477-88
references: 10200966
references: Trends Microbiol. 2009 Mar;17(3):130-8
references: 19231190
references: Caries Res. 2006;40(2):163-71
references: 16508276
references: Clin Diagn Lab Immunol. 2002 Mar;9(2):358-65
references: 11874878
references: Microb Pathog. 1997 Sep;23(3):127-37
references: 9281471
references: J Bacteriol. 2007 Nov;189(22):8300-7
references: 17573475
references: Mol Microbiol. 2000 Mar;35(6):1550-9
references: 10760154
references: Environ Microbiol. 2009 Oct;11(10):2542-55
references: 19549167
references: PLoS One. 2009;4(5):e5513
references: 19436737
references: Science. 2002 Feb 22;295(5559):1487
references: 11859186
references: Mol Microbiol. 2004 Feb;51(3):675-90
references: 14731271
references: Curr Opin Microbiol. 2006 Feb;9(1):12-20
references: 16338163
references: Infect Immun. 2001 Jun;69(6):3755-61
references: 11349040
references: Infect Immun. 2002 Aug;70(8):4059-67
references: 12117912
references: Infect Immun. 1994 Jun;62(6):2582-9
references: 8188381
references: Infect Immun. 2007 Feb;75(2):958-65
references: 17130253
references: Infect Immun. 2004 Oct;72(10):5582-96
references: 15385455
references: Nature. 1995 Oct 5;377(6548):435-8
references: 7566121
references: Infect Immun. 2005 Oct;73(10):6945-51
references: 16177374
references: Adv Exp Med Biol. 2009;634:69-77
references: 19280850
references: Infect Immun. 2000 Aug;68(8):4593-7
references: 10899860
references: J Exp Med. 1944 Feb 1;79(2):137-58
references: 19871359
references: Res Microbiol. 2002 May;153(4):243-7
references: 12066896
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Lancet. 2003 Dec 13;362(9400):1991-2001
references: 14683661
references: Microb Pathog. 1988 Dec;5(6):407-18
references: 2907600
references: Mol Microbiol. 2006 Sep;61(5):1196-210
references: 16925554
references: J Bacteriol. 2009 Mar;191(5):1509-18
references: 19103930
references: Mol Biotechnol. 2004 Jan;26(1):81-6
references: 14734825
references: Antimicrob Agents Chemother. 1978 Feb;13(2):302-11
references: 25618
references: Mol Microbiol. 2002 Jan;43(2):437-48
references: 11985720
references: Mol Microbiol. 2007 Oct;66(2):329-40
references: 17850254
references: Respir Care. 2009 May;54(5):628-40
references: 19393107
references: Stat Appl Genet Mol Biol. 2004;3:Article3
references: 16646809
references: Int J Pediatr Otorhinolaryngol. 2009 Sep;73(9):1242-8
references: 19525016
references: J Infect Dis. 2009 Mar 15;199(6):786-94
references: 19434911
references: Science. 1999 May 21;284(5418):1318-22
references: 10334980